Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers

  • Epizyme (NASDAQ:EPZM) shares increased by 7.3% to $1.32 during Tuesday's after-market session. Epizyme's trading volume hit 240.6K shares by close, accounting for 10.7% of its average volume over the last 100 days. The company's market cap stands at $140.0 million.
  • Viking Therapeutics (NASDAQ:VKTX) stock moved upwards by 6.52% to $4.08. Trading volume for this security closed at 108.0K, accounting for 11.5% of its average full-day volume over the last 100 days. The company's market cap stands at $319.1 million.
  • Agile Therapeutics (NASDAQ:AGRX) stock rose 3.28% to $0.39. The market value of their outstanding shares is at $47.3 million.
  • Enveric Biosciences (NASDAQ:ENVB) shares rose 3.04% to $0.68. The market value of their outstanding shares is at $22.1 million.
  • Celsion (NASDAQ:CLSN) stock increased by 2.89% to $0.48. The market value of their outstanding shares is at $41.5 million.
  • Gritstone Bio (NASDAQ:GRTS) shares moved upwards by 2.89% to $5.68. The company's market cap stands at $386.1 million.

Losers

  • PetVivo Holdings (NASDAQ:PETV) shares fell 4.4% to $1.3 during Tuesday's after-market session. The company's market cap stands at $12.6 million.
  • Quantum-Si (NASDAQ:QSI) shares decreased by 3.53% to $4.65. The market value of their outstanding shares is at $638.9 million.
  • Immix Biopharma (NASDAQ:IMMX) shares declined by 3.48% to $4.45. The company's market cap stands at $33.7 million.
  • Biofrontera (NASDAQ:BFRI) shares fell 3.03% to $4.17. Trading volume for this security closed at 127.9K, accounting for 0.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $62.7 million.
  • PharmaCyte Biotech (NASDAQ:PMCB) shares declined by 2.87% to $2.2. The company's market cap stands at $45.5 million.
  • Gilead Sciences (NASDAQ:GILD) stock decreased by 2.77% to $66.58. Gilead Sciences's trading volume hit 692.7K shares by close, accounting for 8.8% of its average volume over the last 100 days. The company's market cap stands at $83.5 billion. As per the press release, Q4 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.